Last reviewed · How we verify

NCT04306588

Accessing Mobility Using Wearable Sensors

Withdrawn Phase 1, PHASE2 Last updated 27 August 2025
What this trial tests

Phase 1, PHASE2 trial testing Exercise in COPD. Withdrawn.

Timeline
21 May 2018
Primary endpoint
30 December 2025
30 December 2025

Quick facts

Lead sponsorBaylor College of Medicine
PhasePhase 1, PHASE2
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Start date21 May 2018
Primary completion30 December 2025
Estimated completion30 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Baylor College of Medicine

Who can join

18 and older, any sex, with COPD or Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine whether wearable sensors can be used to track changes in cognitive-motor performance in response to a disease or an intervention. The investigators specific aims are twofold, first aim to explore whether and how a clinical condition such as Chronic obstructive pulmonary disease (COPD) or Congestive Heart Failure (CHF) may impact motor-cognitive performance measurable using validated wearable devices (e.g., LEGSys, BalanSENS, and Frailty Meter). Second, the investigators will explore whether an exercise intervention provided via tele-medicine (tele-rehabilitation) can enhance motor-cognitive performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Baylor College of Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04306588.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing